MFDS — authorised 31 July 2018
- Marketing authorisation holder: SHIONOGI INC
- Status: likely_approved
🇰🇷 Mulpleta in South Korea
MFDS authorised Mulpleta on 31 July 2018
Marketing authorisation
Mulpleta in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in South Korea
Frequently asked questions
Is Mulpleta approved in South Korea?
Yes. MFDS authorised it on 31 July 2018.
Who is the marketing authorisation holder for Mulpleta in South Korea?
SHIONOGI INC holds the South Korean marketing authorisation.